Regeneron and Zai Lab to develop and commercialize REGN1979 in China
Category: #headlines  By Pankaj Singh  Date: 2020-04-10
  • share
  • Twitter
  • Facebook
  • LinkedIn

Regeneron and Zai Lab to develop and commercialize REGN1979 in China

American biotechnology company Regeneron Pharmaceuticals is reportedly collaborating with Chinese biopharmaceutical firm Zai Lab Limited to develop and commercialize REGN1979 in mainland China, Taiwan, Hong Kong, and Macau.

REGN1979 is an advanced bispecific monoclonal antibody designed by Regeneron. It is developed to link and activate a lymphoma cell to a cytotoxic T-cell, triggering tumor killing.

As per terms of the deal, Regeneron will receive an upfront payment of US$30 million and will be eligible for an additional US$160 million in regulatory and sales milestones. Zai Lab will bear the expenses pertaining to global development of REGN1979 for several trials.

According to sources familiar with the matter, Regeneron will manufacture and supply REGN1979 for development and commercialization across regions. Zai Lab will obtain rights to develop and commercialize REGN1979 in mainland China, Taiwan, Macau, and Hong Kong. In addition, the company will also pay Regeneron depending upon net sales.

The partnership will foster the global clinical development of REGN1979, beginning with the current phase-2 trial in B-cell non-Hodgkin lymphoma (B-NHL). If approved, Zai Lab will commercialize REGN1979 in these regions.

With its regulatory and clinical expertise along with a notable commercial footprint in, Zai Lab could contribute substantially towards the success of REGN1979.

Also read: QIAGEN deploys QIAstat-Dx Respiratory SARS-CoV-2 test kits in Europe

Regeneron is renowned for its research, development and innovation in medical science, commented Samantha Du, Ph.D., founder, chairperson, and CEO of Zai Lab, adding that the company looks forward to working with the Regeneron group on REGN1979 as it expands its oncology franchise into hematologic cancers.

In collaboration with Regeneron, Zai Lab will look to expand its global effort and deliver innovative solutions to patients, Du added.

Zai Lab, according to Israel Lowy, M.D., Ph.D., Senior VP of Regeneron, is an ideal partner for Regeneron with an outstanding track record which aligns with Regeneron’s mission to leverage the power of science and deliver innovative medical products. Zai Lab will not only help boost the enrolment of REGN1979 into global trials but will also allow this promising investigational drug to reach patients faster, if approved, Lowy said.

 

Source: http://www.zailaboratory.com/in1/index.aspx

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Pankaj Singh    

Pankaj Singh

With a commendable experience of content creation under his belt, Pankaj Singh, a qualified Post Graduate in Management, boasts of having worked as a freelance writer and an insurance underwriter. Additionally, Pankaj has also enriched his qualification portfolio with...

Read More

More News By Pankaj Singh

Fortinet offers firewall for 5G network and hyperscale data centers
Fortinet offers firewall for 5G network and hyperscale data centers
By Pankaj Singh

Leading cybersecurity provider Fortinet has recently unveiled a firewall product focused on 5G networks and hyperscale data center environments. With this move, the firm aims to continue pushing the limits of hardware-accelerate performance around se...

Google Cloud and Informatica expand partnership to boost SAP analytics
Google Cloud and Informatica expand partnership to boost SAP analytics
By Pankaj Singh

Enterprise cloud data management leader, Informatica, has reportedly announced that it has extended its strategic agreement with Google Cloud for the acceleration of analytics with SAP and BigQuery on Google Cloud Platform. The deal integrates Inform...

GOQii to expand health tech offerings to UK, Japan and Southeast Asia
GOQii to expand health tech offerings to UK, Japan and Southeast Asia
By Pankaj Singh

GOQii, health tech company headquartered in California and serving consumers in India, is reportedly planning to expand its operations into global markets like the U.K., Japan and few Southeast Asian countries. It will look to offer its smart wearabl...